Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Nisha Acharya, MD

    TitleAssociate Professor
    SchoolUCSF Chancellor/EVC/FAS
    DepartmentProctor Foundation
    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94143
    Phone415-476-8131

       Overview 
       Overview
      Nisha Acharya is the Director of the Uveitis Service and the Uveitis Fellowship at the F.I. Proctor Foundation. Her clinical expertise is the diagnosis and management of patients with infectious and inflammatory eye diseases. She is experienced with the latest medical and surgical treatments for uveitis, including treatment with new immunomodulatory drugs and cataract surgery in uveitis patients. Dr. Acharya’s research focuses on the design and implementation of clinical trials to determine the optimal treatment for these conditions. Current projects include clinical trials on infectious corneal ulcers, uveitis-related macular edema, and tuberculous uveitis.


       ORNG Applications 
       Websites
       In The News
       Awarded Grants
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014 Oct; 121(10):1863-70.
        View in: PubMed
      2. Ray KJ, Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden DV, Oldenburg CE, Sun CQ, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmol. 2014 Jun 1; 132(6):737-41.
        View in: PubMed
      3. McClintic SM, Prajna NV, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Oldenburg CE, O'Brien KS, Ray KJ, Acharya NR, Lietman TM, Keenan JD. Visual Outcomes in Treated Bacterial Keratitis: Four Years of Prospective Follow-up. Invest Ophthalmol Vis Sci. 2014; 55(5):2935-40.
        View in: PubMed
      4. Borkar DS, Acharya NR, Leong C, Lalitha P, Srinivasan M, Oldenburg CE, Cevallos V, Lietman TM, Evans DJ, Fleiszig SM. Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones. BMC Ophthalmol. 2014; 14(1):54.
        View in: PubMed
      5. Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM. Association between In Vitro Susceptibility to Natamycin and Voriconazole and Clinical Outcomes in Fungal Keratitis. Ophthalmology. 2014 Aug; 121(8):1495-1500.e1.
        View in: PubMed
      6. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Ray KJ, Zegans ME, Acharya NR, Lietman TM, Keenan JD. Visual recovery in treated bacterial keratitis. Ophthalmology. 2014 Jun; 121(6):1310-1311.e3.
        View in: PubMed
      7. Borkar DS, Gonzales JA, Tham VM, Esterberg E, Vinoya AC, Parker JV, Uchida A, Acharya NR. Association between atopy and herpetic eye disease: results from the pacific ocular inflammation study. JAMA Ophthalmol. 2014 Mar 1; 132(3):326-31.
        View in: PubMed
      8. Toutain-Kidd CM, Porco TC, Kidd EM, Srinivasan M, Prajna NV, Acharya N, Lietman T, Zegans ME. Evaluation of Fungal Keratitis using a Newly Developed Computer Program, Optscore, for Grading Digital Corneal Photographs. Ophthalmic Epidemiol. 2014 Feb; 21(1):24-32.
        View in: PubMed
      9. Homayounfar G, Borkar DS, Tham VM, Nardone N, Acharya NR. Clinical characteristics of scleritis and episcleritis: results from the pacific ocular inflammation study. Ocul Immunol Inflamm. 2014 Oct; 22(5):403-4.
        View in: PubMed
      10. Acharya NR, Tham VM, Esterberg E, Borkar DS, Parker JV, Vinoya AC, Uchida A. Incidence and prevalence of uveitis: results from the pacific ocular inflammation study. JAMA Ophthalmol. 2013 Nov 1; 131(11):1405-12.
        View in: PubMed
      11. Lalitha P, Sun CQ, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Cevallos V, McLeod SD, Acharya NR, Lietman TM. In Vitro Susceptibility of Filamentous Fungal Isolates From a Corneal Ulcer Clinical Trial. Am J Ophthalmol. 2014 Feb; 157(2):318-26.
        View in: PubMed
      12. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR. The Steroids for Corneal Ulcers Trial (SCUT): Secondary 12-Month Clinical Outcomes of a Randomized Controlled Trial. Am J Ophthalmol. 2014 Feb; 157(2):327-333.e3.
        View in: PubMed
      13. Prajna NV, O'Brien KS, Acharya NR, Lietman TM. Voriconazole for fungal keratitis. Ophthalmology. 2013 Sep; 120(9):e62-3.
        View in: PubMed
      14. Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, Mascarenhas J, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol. 2013 Aug; 131(8):1088-9.
        View in: PubMed
      15. Rose-Nussbaumer J, Goldstein DA, Thorne JE, Arantes TE, Acharya NR, Shakoor A, Jeng BH, Yeh S, Rahman H, Vemulakonda GA, Flaxel CJ, West SK, Holland GN, Smith JR. Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL. Clin Experiment Ophthalmol. 2014 Mar; 42(2):118-25.
        View in: PubMed
      16. Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, Parker JV, Vinoya AC, Uchida A, Acharya NR. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013 Oct; 156(4):752-8.
        View in: PubMed
      17. Shakoor A, Esterberg E, Acharya NR. Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm. 2014 Apr; 22(2):96-101.
        View in: PubMed
      18. Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, Raghavan A, O'Brien KS, Ray KJ, McLeod SD, Porco TC, Acharya NR, Lietman TM. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I. Invest Ophthalmol Vis Sci. 2013 Jun; 54(6):4167-73.
        View in: PubMed
      19. Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology. 2013 Sep; 120(9):1852-9.
        View in: PubMed
      20. Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Borkar DS, Ray KJ, Zegans ME, McLeod SD, Porco TC, Lietman TM, Acharya NR. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol. 2013 Jun; 20(3):155-8.
        View in: PubMed
      21. Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, Raghavan A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Porco TC, Acharya NR, Lietman TM. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013 Apr; 131(4):422-9.
        View in: PubMed
      22. Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013 Mar; 131(3):310-3.
        View in: PubMed
      23. Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci. 2013 Feb; 54(2):1522-6.
        View in: PubMed
      24. Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol. 2013 Feb; 131(2):147-53.
        View in: PubMed
      25. McClintic SM, Srinivasan M, Mascarenhas J, Greninger DA, Acharya NR, Lietman TM, Keenan JD. Improvement in corneal scarring following bacterial keratitis. Eye (Lond). 2013 Mar; 27(3):443-6.
        View in: PubMed
      26. Borkar DS, Tham VM, Esterberg E, Ray KJ, Vinoya AC, Parker JV, Uchida A, Acharya NR. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology. 2013 Mar; 120(3):451-6.
        View in: PubMed
      27. See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiol. 2012 Dec; 19(6):407-13.
        View in: PubMed
      28. Lin CC, Lalitha P, Srinivasan M, Prajna NV, McLeod SD, Acharya NR, Lietman TM, Porco TC. Seasonal trends of microbial keratitis in South India. Cornea. 2012 Oct; 31(10):1123-7.
        View in: PubMed
      29. Gonzales JA, Levison AL, Stewart JM, Acharya NR, Margolis TP. Retinal necrosis following varicella-zoster vaccination. Arch Ophthalmol. 2012 Oct; 130(10):1355-6.
        View in: PubMed
      30. Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012 Dec; 154(6):934-939.e1.
        View in: PubMed
      31. Prajna VN, Lalitha PS, Mascarenhas J, Krishnan T, Srinivasan M, Vaitilingam CM, Oldenburg CE, Sy A, Keenan JD, Porco TC, Acharya NR, Lietman TM. Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial. Br J Ophthalmol. 2012 Nov; 96(11):1440-1.
        View in: PubMed
      32. Yoder JS, Verani J, Heidman N, Hoppe-Bauer J, Alfonso EC, Miller D, Jones DB, Bruckner D, Langston R, Jeng BH, Joslin CE, Tu E, Colby K, Vetter E, Ritterband D, Mathers W, Kowalski RP, Acharya NR, Limaye AP, Leiter C, Roy S, Lorick S, Roberts J, Beach MJ. Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiol. 2012 Aug; 19(4):221-5.
        View in: PubMed
      33. Sy A, McLeod SD, Cohen EJ, Margolis TP, Mannis MJ, Lietman TM, Acharya NR. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea. 2012 Jul; 31(7):786-90.
        View in: PubMed
      34. Mascarenhas J, Srinivasan M, Chen M, Rajaraman R, Ravindran M, Lalitha P, Oldenburg CE, Ray KJ, Glidden DV, Costanza S, Lietman TM, Acharya NR. Differentiation of etiologic agents of bacterial keratitis from presentation characteristics. Int Ophthalmol. 2012 Dec; 32(6):531-8.
        View in: PubMed
      35. Prajna NV, Krishnan T, Mascarenhas J, Srinivasan M, Oldenburg CE, Toutain-Kidd CM, Sy A, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Porco TC. Predictors of outcome in fungal keratitis. Eye (Lond). 2012 Sep; 26(9):1226-31.
        View in: PubMed
      36. Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, Vaitilingam CM, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea. 2012 Jun; 31(6):662-7.
        View in: PubMed
      37. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Glidden D, Oldenburg CE, Whitcher JP, Zegans ME, McLeod SD, Lietman TM, Acharya NR, Steroids For Corneal Ulcers Trial Group FT. Subgroup analysis in the steroids for corneal ulcers trial-reply. Arch Ophthalmol. 2012 Jun 1; 130(6):807-8.
        View in: PubMed
      38. Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, Kumar JA, Mascarenhas J, Margolis TP, Whitcher JP, Jeng BH, Keenan JD, Chan MF, McLeod SD, Acharya NR. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012 Apr; 53(4):1787-91.
        View in: PubMed
      39. Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis. 2012 May; 54(10):1381-7.
        View in: PubMed
      40. Lalitha P, Lin CC, Srinivasan M, Mascarenhas J, Prajna NV, Keenan JD, McLeod SD, Acharya NR, Lietman TM, Porco TC. Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics. Ophthalmic Epidemiol. 2012 Apr; 19(2):111-5.
        View in: PubMed
      41. Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb; 20(1):18-26.
        View in: PubMed
      42. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci. 2012 Jan; 53(1):267-72.
        View in: PubMed
      43. Tranos PG, Moore A, Pavesio C, Acharya NR, Johnson MW. Diagnostic and therapeutic challenges. Retina. 2012 Jan; 32(1):191-6.
        View in: PubMed
      44. Oldenburg CE, Acharya NR, Tu EY, Zegans ME, Mannis MJ, Gaynor BD, Whitcher JP, Lietman TM, Keenan JD. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea. 2011 Dec; 30(12):1363-8.
        View in: PubMed
      45. Esterberg E, Acharya NR. Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect. 2012 Mar; 2(1):21-8.
        View in: PubMed
      46. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol. 2012 Feb; 130(2):151-7.
        View in: PubMed
      47. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012 Feb; 130(2):143-50.
        View in: PubMed
      48. Krishnan T, Prajna NV, Gronert K, Oldenburg CE, Ray KJ, Keenan JD, Lietman TM, Acharya NR. Gender differences in re-epithelialisation time in fungal corneal ulcers. Br J Ophthalmol. 2012 Jan; 96(1):137-8.
        View in: PubMed
      49. Acharya NR, Sittivarakul W, Qian Y, Hong KC, Lee SM. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema. Retina. 2011 Oct; 31(9):1871-6.
        View in: PubMed
      50. Qian Y, Glaser T, Esterberg E, Acharya NR. Depression and visual functioning in patients with ocular inflammatory disease. Am J Ophthalmol. 2012 Feb; 153(2):370-378.e2.
        View in: PubMed
      51. Sugar EA, Jabs DA, Altaweel MM, Lightman S, Acharya N, Vitale AT, Thorne JE. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. Am J Ophthalmol. 2011 Dec; 152(6):1044-1052.e5.
        View in: PubMed
      52. Oldenburg CE, Sy A, Srinivasan M, Toutain-Kidd CM, Mascarenhas J, Ravindran M, Rajaraman R, Esterberg EJ, Chidambaram JD, Acharya NR, Lietman TM, Zegans ME. Pre-existing blindness in a cohort of patients with bacterial keratitis. Br J Ophthalmol. 2011 Nov; 95(11):1612-3.
        View in: PubMed
      53. Oldenburg CE, Keenan JD, Cevallos V, Chan MF, Acharya NR, Gaynor BD, McLeod SD, Esterberg EJ, Porco TC, Lietman TM. Microbiological cure times in acanthamoeba keratitis. Eye (Lond). 2011 Sep; 25(9):1155-60.
        View in: PubMed
      54. Keenan JD, Lakew T, Alemayehu W, Melese M, House JI, Acharya NR, Porco TC, Gaynor BD, Lietman TM. Slow resolution of clinically active trachoma following successful mass antibiotic treatments. Arch Ophthalmol. 2011 Apr; 129(4):512-3.
        View in: PubMed
      55. Fintelmann RE, Hoskins EN, Lietman TM, Keenan JD, Gaynor BD, Cevallos V, Acharya NR. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Arch Ophthalmol. 2011 Apr; 129(4):399-402.
        View in: PubMed
      56. Oldenburg CE, Prajna VN, Prajna L, Krishnan T, Mascarenhas J, Vaitilingam CM, Srinivasan M, See CW, Cevallos V, Zegans ME, Acharya NR, Lietman TM. Clinical signs in dematiaceous and hyaline fungal keratitis. Br J Ophthalmol. 2011 May; 95(5):750-1.
        View in: PubMed
      57. Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2010 Nov; 21(6):468-72.
        View in: PubMed
      58. Lalitha P, Shapiro BL, Loh AR, Fothergill AW, Prajna NV, Srinivasan M, Oldenburg CE, Quigley DA, Chidambaram JD, McLeod SD, Acharya NR, Lietman TM. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis. Br J Ophthalmol. 2011 May; 95(5):744-5.
        View in: PubMed
      59. Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol. 2010 Oct; 150(4):534-542.e2.
        View in: PubMed
      60. Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, Vaitilingam CM, Hong KC, Lee SM, McLeod SD, Zegans ME, Porco TC, Lietman TM, Acharya NR. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010 Jun; 128(6):672-8.
        View in: PubMed
      61. Khalifa YM, Bailony MR, Acharya NR. Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab. Ocul Immunol Inflamm. 2010 Jun; 18(3):218-22.
        View in: PubMed
      62. Budhathoki N, Shrestha MK, Acharya N, Manandhar A. Substance use among third year medical students of Nepal. J Nepal Health Res Counc. 2010 Apr; 8(1):15-8.
        View in: PubMed
      63. Keenan JD, Lakew T, Alemayehu W, Melese M, Porco TC, Yi E, House JI, Zhou Z, Ray KJ, Acharya NR, Whitcher JP, Gaynor BD, Lietman TM. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg. 2010 Mar; 82(3):482-7.
        View in: PubMed
      64. Shapiro BL, Lalitha P, Loh AR, Fothergill AW, Prajna NV, Srinivasan M, Kabra A, Chidambaram J, Acharya NR, Lietman TM. Susceptibility testing and clinical outcome in fungal keratitis. Br J Ophthalmol. 2010 Mar; 94(3):384-5.
        View in: PubMed
      65. Khalifa YM, Monahan PM, Acharya NR. Ampiginous choroiditis following quadrivalent human papilloma virus vaccine. Br J Ophthalmol. 2010 Jan; 94(1):137-9.
        View in: PubMed
      66. Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology. 2010 Mar; 117(3):585-90.
        View in: PubMed
      67. Khalifa Y, Loh AR, Acharya NR. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2009 Nov-Dec; 17(6):431-3.
        View in: PubMed
      68. Acharya NR, Srinivasan M, Mascarenhas J, Ravindran M, Rajaraman R, Zegans M, McLeod S, Lietman TM. The steroid controversy in bacterial keratitis. Arch Ophthalmol. 2009 Sep; 127(9):1231.
        View in: PubMed
      69. Loh AR, Hong K, Lee S, Mannis M, Acharya NR. Practice patterns in the management of fungal corneal ulcers. Cornea. 2009 Sep; 28(8):856-9.
        View in: PubMed
      70. Acharya NR, Hong KC, Lee SM. Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol. 2009 Aug; 148(2):303-309.e2.
        View in: PubMed
      71. Nagpal A, Vora R, Margolis TP, Acharya NR. Interstitial keratitis following varicella vaccination. Arch Ophthalmol. 2009 Feb; 127(2):222-3.
        View in: PubMed
      72. Acharya N, Lois N, Townend J, Zaher S, Gallagher M, Gavin M. Socio-economic deprivation and visual acuity at presentation in exudative age-related macular degeneration. Br J Ophthalmol. 2009 May; 93(5):627-9.
        View in: PubMed
      73. Day S, Lalitha P, Haug S, Fothergill AW, Cevallos V, Vijayakumar R, Prajna NV, Acharya NR, McLeod SD, Lietman TM. Activity of antibiotics against Fusarium and Aspergillus. Br J Ophthalmol. 2009 Jan; 93(1):116-9.
        View in: PubMed
      74. Srinivasan M, Lalitha P, Mahalakshmi R, Prajna NV, Mascarenhas J, Chidambaram JD, Lee S, Hong KC, Zegans M, Glidden DV, McLeod S, Whitcher JP, Lietman TM, Acharya NR. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol. 2009 Feb; 93(2):198-202.
        View in: PubMed
      75. Acharya NR, Srinivasan M, Kundu A, Lietman TM, Whitcher JP, Cunningham ET. Mooren''s ulcer following extracapsular cataract extraction. Eur J Ophthalmol. 2008 May-Jun; 18(3):351-5.
        View in: PubMed
      76. Sansanayudh W, Cevallos V, Porco TC, Margolis TP, Lietman TM, Acharya NR. Fusarium and Acanthamoeba keratitis: can a single centre detect outbreaks? Br J Ophthalmol. 2008 May; 92(5):720-1.
        View in: PubMed
      77. Leigh JF, Acharya N, Cevallos V, Margolis TP. Does asymptomatic shedding of herpes simplex virus on the ocular surface lead to false-positive diagnostic PCR results? Br J Ophthalmol. 2008 Mar; 92(3):435-6.
        View in: PubMed
      78. Chen A, Prajna L, Srinivasan M, Mahalakshmi R, Whitcher JP, McLeod S, Lietman TM, Acharya NR. Does in vitro susceptibility predict clinical outcome in bacterial keratitis? Am J Ophthalmol. 2008 Mar; 145(3):409-412.
        View in: PubMed
      79. Nagpal A, Leigh JF, Acharya NR. Epidemiology of uveitis in children. Int Ophthalmol Clin. 2008; 48(3):1-7.
        View in: PubMed
      80. Chibber KS, Kaplan RL, Padian NS, Anderson SJ, Ling PM, Acharya N, Van Dyke C, Krishnan S. A common pathway toward women's health. Glob Public Health. 2008; 3(1):26-38.
        View in: PubMed
      81. Rutar T, Chan MF, Acharya NR, Naseri A. Cicatrising conjunctivitis due to paraneoplastic pemphigoid. Br J Ophthalmol. 2007 Nov; 91(11):1562-3.
        View in: PubMed
      82. Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007 Dec; 144(6):850-857.
        View in: PubMed
      83. Freidlin J, Wong IG, Acharya N. Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis. Br J Ophthalmol. 2007 Oct; 91(10):1414.
        View in: PubMed
      84. Acharya NR, Lietman TM, Margolis TP. Parasites on the rise: a new epidemic of Acanthamoeba keratitis. Am J Ophthalmol. 2007 Aug; 144(2):292-3.
        View in: PubMed
      85. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007 Aug; 144(2):313-5.
        View in: PubMed
      86. Kaiser PK, Blodi BA, Shapiro H, Acharya NR. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007 Oct; 114(10):1868-75.
        View in: PubMed
      87. Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, Ruiz J, Chidambaram JD, Maxey KJ, Hong KC, McLeod SD, Lietman TM. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. 2007 Jun; 125(6):789-93.
        View in: PubMed
      88. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007 Feb; 114(2):246-52.
        View in: PubMed
      89. Ou JI, Acharya NR. Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin. 2007; 47(3):7-16.
        View in: PubMed
      90. Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG. Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol. 2006 Jul; 124(7):1051-3.
        View in: PubMed
      91. Acharya N, Lietman T, Cevallos V, Whitcher JP, Saidel M, Stone D, Duncan J, Margolis TP. Correlation between clinical suspicion and polymerase chain reaction verification of infectious vitritis. Am J Ophthalmol. 2006 Mar; 141(3):584-5.
        View in: PubMed
      92. Acharya N, Pineda R, Uy HS, Foster CS. Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology. 2005 May; 112(5):e19-23.
        View in: PubMed
      93. Acharya N, Young L. Sustained-release drug implants for the treatment of intraocular disease. Int Ophthalmol Clin. 2004; 44(3):33-9.
        View in: PubMed
      94. Acharya NR, Cunningham ET. Corneal, anterior segment, and adnexal manifestations of human immunodeficiency virus. Int Ophthalmol Clin. 1998; 38(4):161-77.
        View in: PubMed
      Nisha's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP